For citations:
Rumyantsev AA, Tyulyandina AS, Pokataev IA, Israelyan ER, Abramov MЕ, Lud HN, Tyulyandin SA. Olaparib maintenance therapy after frontline chemotherapy in patients with BRCA-mutated ovarian cancer: real-world results in expanded access program. Meditsinskiy sovet = Medical Council. 2022;(9):77-83. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-9-77-83